AAP releases influenza vaccine recommendations for all children 6 months and older
Researchers from the American Academy of Pediatrics Committee on Infectious Diseases updated recommendations for the use of influenza vaccines and antiviral medications in the prevention and treatment of influenza in children during the 2026–2027 influenza season.
The American Academy of Pediatrics has released updated influenza vaccine recommendations for all children aged 6 months and older for the 2026-2027 influenza season. The guidelines, published in the journal Pediatrics, advise that any licensed, age- and health-status-appropriate vaccine can be administered as soon as the season begins.
For children hospitalized or experiencing severe or progressive disease, antiviral treatment is recommended. In ambulatory settings, high-risk children, including those with chronic medical conditions and immunocompromised patients, should be offered antiviral treatment. Antiviral treatment is also recommended for all children with suspected or confirmed influenza in ambulatory settings.
The AAP notes that influenza vaccination coverage was low during the 2025-2026 season, with only 49.4% of children receiving vaccinations.
Brief written by urgent.news from Medical Xpress's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
